Ryuichi Kawamoto Selected Research

Ryuichi Kawamoto Research Topics

Disease

23	Insulin Resistance 11/2016 - 06/2007
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2019 - 09/2005
19	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 08/2005
10	Carotid Artery Diseases 01/2016 - 11/2002
9	Hypertension (High Blood Pressure) 01/2020 - 09/2005
7	Type 2 Diabetes Mellitus (MODY) 01/2016 - 06/2007
6	Atherosclerosis 01/2014 - 01/2002
5	Prehypertension 01/2014 - 11/2008
5	Diabetes Mellitus 08/2006 - 01/2003
4	Abdominal Obesity 02/2014 - 09/2005
3	Body Weight (Weight, Body) 01/2016 - 03/2008
3	Overweight 09/2013 - 08/2009
3	Coronary Disease (Coronary Heart Disease) 01/2011 - 04/2010
2	Neoplasms (Cancer) 01/2019 - 01/2007
2	Sarcopenia 01/2016 - 04/2015
2	Inflammation (Inflammations) 09/2013 - 06/2011
2	Obesity 07/2013 - 01/2011
2	Ischemic Stroke 03/2005 - 01/2002
1	Hyperuricemia 06/2022
1	Renal Insufficiency (Renal Failure) 06/2021
1	Constipation 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2020
1	Disease Progression 05/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Glucose Intolerance 01/2013
1	Renal hypouricemia 01/2010
1	Dyslipidemias (Dyslipidemia) 01/2008
1	Hypotension (Low Blood Pressure) 06/2007
1	Type 2 Hdl Deficiency 06/2007
1	Hemorrhage 01/2007
1	Hypertriglyceridemia 09/2005
1	Cerebral Infarction 09/2005
1	Hyperlipidemias (Hyperlipidemia) 10/2004
1	Infections 07/2003
1	Nutrition Disorders (Nutritional Disorders) 01/2002

Drug/Important Bio-Agent (IBA)

18	Uric Acid (Urate)IBA 06/2022 - 08/2005
13	AdiponectinIBA 02/2014 - 01/2008
10	Biomarkers (Surrogate Marker)IBA 07/2020 - 12/2005
10	HDL CholesterolIBA 02/2014 - 01/2002
9	Triglycerides (Triacylglycerol)IBA 05/2016 - 02/2010
8	LDL CholesterolIBA 09/2021 - 01/2005
8	C-Reactive ProteinIBA 09/2013 - 08/2006
7	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 08/2006
7	Glucose (Dextrose)FDA LinkGeneric 02/2014 - 01/2002
6	oxidized low density lipoproteinIBA 09/2021 - 01/2005
6	ResistinIBA 11/2016 - 06/2007
5	ORALIT (ORS)IBA 01/2020 - 11/2008
5	BilirubinIBA 03/2019 - 01/2014
5	LipidsIBA 02/2014 - 01/2002
4	CholesterolIBA 01/2016 - 01/2002
4	TransferasesIBA 04/2012 - 11/2008
3	Indicators and Reagents (Reagents)IBA 06/2022 - 04/2015
3	Hemoglobins (Hemoglobin)IBA 04/2013 - 01/2011
3	Insulin (Novolin)FDA Link 09/2010 - 07/2008
2	CreatinineIBA 01/2019 - 01/2006
2	Alanine Transaminase (SGPT)IBA 10/2017 - 10/2012
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015 - 01/2014
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2013 - 06/2011
1	Sennosides (Senokot)IBA 01/2021
1	Lubiprostone FDA Link 01/2021
1	CalciumIBA 01/2021
1	Immunoglobulin D (IgD)IBA 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	CytokinesIBA 11/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2015
1	Malondialdehyde (Propanedial)IBA 04/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2012
1	lipoprotein cholesterolIBA 06/2011
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2011
1	Biological ProductsIBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	AdipokinesIBA 01/2011
1	Nonsense Codon (Nonsense Mutation)IBA 01/2010
1	PPAR gammaIBA 09/2009
1	Ethanol (Ethyl Alcohol)IBA 08/2009
1	MitogensIBA 07/2008
1	Insulin Receptor Substrate ProteinsIBA 07/2008
1	Serine (L-Serine)FDA Link 07/2008
1	Mitogen-Activated Protein Kinase 8IBA 07/2008
1	Phosphotransferases (Kinase)IBA 07/2008
1	Blood Proteins (Serum Proteins)IBA 03/2008
1	Oxidoreductases (Dehydrogenase)IBA 03/2005
1	5,10-methylenetetrahydrofolic acidIBA 03/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2004
1	ImmunosorbentsIBA 07/2003
1	EnzymesIBA 07/2003
1	Immunoglobulin G (IgG)IBA 07/2003
1	Pharmaceutical PreparationsIBA 01/2003
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2002
1	HomocysteineIBA 01/2002

Therapy/Procedure

1	Craniotomy 01/2007